Diphenhydramine Poison Ivy Caution Not Required On External Analgesics
This article was originally published in The Tan Sheet
Executive Summary
Topical diphenhydramine products will not be required to carry warnings against use on poison ivy, sunburns and broken skin under an FDA 1final rule published in the Federal Register Dec. 6
You may also be interested in...
OTC Supplemental Warning Regs Need Not Show Causation – FDA’s Troy
FDA does not have to prove causality in order to require new warnings in the labeling of OTC drugs, Chief Counsel Daniel Troy clarified at the Generic Pharmaceutical Association's legal symposium in Washington, D.C. May 16
OTC Supplemental Warning Regs Need Not Show Causation – FDA’s Troy
FDA does not have to prove causality in order to require new warnings in the labeling of OTC drugs, Chief Counsel Daniel Troy clarified at the Generic Pharmaceutical Association's legal symposium in Washington, D.C. May 16
OTC Supplemental Warning Regs Need Not Show Causation – FDA’s Troy
FDA does not have to prove causality in order to require new warnings in the labeling of OTC drugs, Chief Counsel Daniel Troy clarified at the Generic Pharmaceutical Association's legal symposium in Washington, D.C. May 16